Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2
Submitted: 9 January 2014
Accepted: 8 April 2014
Published: 20 March 2015
Accepted: 8 April 2014
Abstract Views: 1138
PDF: 769
HTML: 276
HTML: 276
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.